Drugs / Livitol-70
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03503708 | May → Oct 2018 overdue | alcoholic liver disease | Composite Interceptive Med Science | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Livitol-70 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03503708 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “herbal supplement” NCT03503708 ↗ |
| Route | Oral | “Participant will be instructed to take two capsule twice daily at a fixed time in the day.” NCT03503708 ↗ |